TNGX 7.97 ▲ 2.18% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tango Therapeutics Inc.

    NASDAQ: TNGX · Real-Time Price · USD
    7.97
    0.17 (2.18%)
    At close: Sep 25, 2025, 3:59 PM
    7.97
    0.00%
    After-hours: Sep 25, 2025, 05:22 PM EDT
    2.18%
    Bid 7.55
    Market Cap 886.74M
    Revenue (ttm) 24.3M
    Net Income (ttm) -145.57M
    EPS (ttm) -1.32
    PE Ratio (ttm) -6.04
    Forward PE -5.2
    Analyst Buy
    Dividends n/a
    Ask 8.2
    Volume 3,193,858
    Avg. Volume (20D) 2,055,676
    Open 7.47
    Previous Close 7.80
    Day's Range 7.46 - 8.19
    52-Week Range 1.03 - 8.19
    Beta 1.65
    Ex-Dividend Date n/a

    About TNGX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol TNGX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for TNGX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Tango Therapeutics Inc. is scheduled to release its earnings on Nov 5, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    10 months ago
    -37.45%
    Tango Therapeutics shares are trading lower after ... Unlock content with Pro Subscription
    news image

    1 week ago · zacks.com

    Tango Therapeutics (TNGX) Soars 7.8%: Is Further Upside Left in the Stock?

    Tango Therapeutics (TNGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more ...

    news image

    1 month ago · fool.com

    Tango (TNGX) Q2 Revenue Drops 52%

    Tango (TNGX) Q2 Revenue Drops 52%

    news image

    1 month ago · zacks.com

    Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates

    Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.35 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.24 per share a year ago.

    news image

    1 month ago · zacks.com

    Wall Street Analysts Believe Tango Therapeutics (TNGX) Could Rally 61.46%: Here's is How to Trade

    The mean of analysts' price targets for Tango Therapeutics (TNGX) points to a 61.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amo...

    news image

    1 month ago · zacks.com

    Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    Tango Therapeutics (TNGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    2 months ago · zacks.com

    Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect?

    The mean of analysts' price targets for Tango Therapeutics (TNGX) points to a 75.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amo...

    Add to Watchlist